...
首页> 外文期刊>American Journal of Pharmacological Sciences >QSAR Study of Methionine Aminopeptidase Inhibitors as Anti-cancer Agents Using MLR Approach
【24h】

QSAR Study of Methionine Aminopeptidase Inhibitors as Anti-cancer Agents Using MLR Approach

机译:使用MLR方法对蛋氨酸氨基肽酶抑制剂作为抗癌药进行QSAR研究

获取原文

摘要

Here Benzimidazole analogues have been used to correlate the inhibition activity with the Eccentric Connectivity index (ECI), Fragment Complexity (FC) and McGowan Volumes (MG) descriptors for studying the quantitative structure activity relationship (QSAR) against methionine aminopeptidases for the development and evaluation of anti-cancer agents. Correlation may be an adequate predictive model which can help to provide guidance in designing and subsequently yielding greatly specific compounds that may have reduced side effects and improved pharmacological activities. We have used Multiple Linear Regression (MLR) for developing QSAR model. For the validation of the developed QSAR model, statistical analysis such as cross validation test (LOO-CV), quality factor, fischers test, root mean square deviation (RMSD), variance, standard deviation etc.; have been performed and all the tests validated this QSAR model with fraction of variance r2 = 0.8906 and LOO-CV q2 = 0.8904.
机译:此处使用苯并咪唑类似物将抑制活性与偏心连接指数(ECI),片段复杂度(FC)和McGowan Volumes(MG)描述符相关联,以研究针对蛋氨酸氨基肽酶的定量结构活性关系(QSAR),以进行开发和评估抗癌药。相关性可能是适当的预测模型,可以帮助提供设计指导,并随后提供可降低副作用和改善药理活性的特异化合物。我们已经使用多元线性回归(MLR)来开发QSAR模型。为了验证已开发的QSAR模型,需要进行统计分析,例如交叉验证检验(LOO-CV),品质因数,费歇尔检验,均方根偏差(RMSD),方差,标准偏差等;已经进行了所有测试,并验证了该QSAR模型的方差分数r2 = 0.8906和LOO-CV q2 = 0.8904。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号